| Breakdown | TTM | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 | Feb 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 467.40M | 790.30M | 1.46B | 1.77B | 1.98B | 1.75B |
| Gross Profit | 197.40M | 389.70M | 756.10M | 895.20M | 1.04B | 945.20M |
| EBITDA | -58.90M | -184.90M | -53.70M | -10.80M | 63.20M | 154.80M |
| Net Income | -202.20M | -326.40M | -137.80M | -75.60M | -4.00M | 90.70M |
Balance Sheet | ||||||
| Total Assets | 469.90M | 525.90M | 1.08B | 1.23B | 998.40M | 775.90M |
| Cash, Cash Equivalents and Short-Term Investments | 30.40M | 44.70M | 230.00M | 330.90M | 101.30M | 276.00M |
| Total Debt | 217.20M | 243.10M | 446.90M | 463.60M | 151.90M | 18.30M |
| Total Liabilities | 469.80M | 522.00M | 795.70M | 825.70M | 534.10M | 303.40M |
| Stockholders Equity | 100.00K | 3.90M | 279.70M | 400.00M | 464.30M | 472.50M |
Cash Flow | ||||||
| Free Cash Flow | -4.30M | -34.00M | -62.90M | 45.50M | -251.20M | 40.10M |
| Operating Cash Flow | -30.00M | -12.70M | 1.90M | 136.70M | 10.30M | 162.80M |
| Investing Cash Flow | 42.20M | 32.20M | -54.80M | -103.30M | -261.50M | -283.40M |
| Financing Cash Flow | -111.70M | -202.90M | -48.00M | 196.20M | 76.50M | 151.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £2.98B | 2.38 | 21.64% | ― | -6.43% | 52.93% | |
68 Neutral | £3.63B | 9.49 | 15.14% | 1.21% | 10.51% | -7.47% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £19.79M | -2.99 | -5.59% | ― | -1.65% | -454.55% | |
54 Neutral | £260.24M | -0.65 | -155.17% | ― | -15.00% | 21.71% | |
52 Neutral | £560.53M | -8.29 | 12.75% | ― | -1.91% | ― | |
41 Neutral | £260.28M | -3.32 | -9999.00% | ― | -65.42% | 27.73% |